» Articles » PMID: 10377145

Differential Regulation of Immune Responses by Highly and Weakly Virulent Cryptococcus Neoformans Isolates

Overview
Journal Infect Immun
Date 1999 Jun 22
PMID 10377145
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Early inflammatory responses, delayed-type hypersensitivity (DTH) responses, and cytokine profiles were studied in mice infected by the pulmonary route with either a highly virulent isolate (NU-2) or a weakly virulent isolate (184A) of Cryptococcus neoformans. After infection, NU-2 remained in the lungs and the capsule became more pronounced during the first 24 h, whereas 184A induced an immediate inflammatory reaction and was rapidly cleared from the lungs. Cryptococcal antigen (GXM) appeared in sera early after infection with NU-2 and increased over the entire observation period. There was no detectable GXM in sera from 184A-infected mice. Both C. neoformans isolates induced anticryptococcal cell-mediated immune responses, but the responses had different profiles. DTH in NU-2-infected mice appeared at day 15 after infection and waned by day 21, whereas DTH in 184A-infected mice was present by day 5 and continued to increase. T helper 1 (Th1) cytokines (interleukin 2 [IL-2] and gamma interferon) were made by spleen cells early after infection with either isolate. NU-2-infected mice lost their ability to produce these cytokines, but 184A-infected mice retained it. IL-4, a Th2 cytokine, was not detected in infected mice. The regulatory cytokine IL-10 was made by spleen cells early but not later after infection with the highly virulent isolate and was not produced by spleen cells from 184A-infected mice. IL-10-deficient mice survived an NU-2 infection significantly longer than wild-type mice, suggesting that IL-10 is important in down-regulating the protective immune response. The induction of anergy appears to be responsible for the inability of NU-2-infected mice to control a C. neoformans infection.

Citing Articles

Immunomodulatory Role of Capsular Polysaccharides Constituents of .

Decote-Ricardo D, LaRocque-de-Freitas I, Rocha J, Nascimento D, Nunes M, Morrot A Front Med (Lausanne). 2019; 6:129.

PMID: 31275938 PMC: 6593061. DOI: 10.3389/fmed.2019.00129.


Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Teitz-Tennenbaum S, Viglianti S, Roussey J, Levitz S, Olszewski M, Osterholzer J J Immunol. 2018; 201(7):2004-2015.

PMID: 30097531 PMC: 6145088. DOI: 10.4049/jimmunol.1800070.


Fungal Strategies to Evade the Host Immune Recognition.

Hernandez-Chavez M, Perez-Garcia L, Nino-Vega G, Mora-Montes H J Fungi (Basel). 2018; 3(4).

PMID: 29371567 PMC: 5753153. DOI: 10.3390/jof3040051.


Immunoregulation in Fungal Diseases.

Roussey J, Olszewski M, Osterholzer J Microorganisms. 2016; 4(4).

PMID: 27973396 PMC: 5192530. DOI: 10.3390/microorganisms4040047.


Cryptococcal therapies and drug targets: the old, the new and the promising.

Coelho C, Casadevall A Cell Microbiol. 2016; 18(6):792-9.

PMID: 26990050 PMC: 5536168. DOI: 10.1111/cmi.12590.


References
1.
Bulmer G, Sans M . Cryptococcus neoformans. 3. Inhibition of phagocytosis. J Bacteriol. 1968; 95(1):5-8. PMC: 251963. DOI: 10.1128/jb.95.1.5-8.1968. View

2.
Blackstock R, Murphy J . Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. Infect Immun. 1997; 65(10):4114-21. PMC: 175592. DOI: 10.1128/iai.65.10.4114-4121.1997. View

3.
Howard M, OGarra A . Biological properties of interleukin 10. Immunol Today. 1992; 13(6):198-200. DOI: 10.1016/0167-5699(92)90153-X. View

4.
Buchanan K, Murphy J . Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun. 1993; 61(7):2854-65. PMC: 280931. DOI: 10.1128/iai.61.7.2854-2865.1993. View

5.
Bermudez L, Champsi J . Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun. 1993; 61(7):3093-7. PMC: 280968. DOI: 10.1128/iai.61.7.3093-3097.1993. View